The antimicrobial peptide Ci-MAM-A24 is highly active against multidrug-resistant and anaerobic bacteria pathogenic for humans

International Journal of Antimicrobial Agents

Volumn 36, Issue 3, 2010, Pages 264-266

  Fedders, Henning ^a   Podschun, Rainer ^a   Leippe, Matthias ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Anaerobic bacteria; Antimicrobial peptide; Ci MAM A24; Ciona intestinalis; Multidrug resistant bacteria

Indexed keywords

MAM A24; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; CIONA INTESTINALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; CHEMISTRY; DRUG EFFECTS; ENTEROCOCCUS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; SYNTHESIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CIONA INTESTINALIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 77954952692     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.04.008     Document Type: Article

References (15)

1. Oyston P.C.F., Fox M.A., Richards S.J., Clark G.C. Novel peptide therapeutics for treatment of infections. J Med Microbiol 2009, 58:977-987.
2. Wang G., Li X., Wang Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 2009, 37:D933-D937.
3. Hancock R.E., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006, 24:1551-1557.
4. Mayer A.M., Rodríguez A.D., Berlinck R.G., Hamann M.T. Marine pharmacology in 2005-6: marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim Biophys Acta 2009, 1790:283-308.
5. Tincu J.A., Taylor S.W. Antimicrobial peptides from marine invertebrates. Antimicrob Agents Chemother 2004, 48:3645-3654.
6. Fedders H., Leippe M. A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity. Dev Comp Immunol 2008, 32:286-298.
7. Fedders H., Michalek M., Grötzinger J., Leippe M. An exceptional salt-tolerant antimicrobial peptide derived from a novel gene family of haemocytes of the marine invertebrate Ciona intestinalis. Biochem J 2008, 416:65-75.
8. Paterson D.L. Clinical experience with recently approved antibiotics. Curr Opin Pharmacol 2006, 6:486-490.
9. Liu C.Y., Huang Y.T., Liao C.H., Yen L.C., Lin H.Y., Hsueh P.R. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrob Agents Chemother 2008, 52:3161-3168.
10. Marr A.K., Gooderham W.J., Hancock R.E. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 2006, 6:468-472.
11. Boman H.G., Nilsson-Faye I., Paul K., Rasmuson T. Insect immunity. I. Characteristics of an inducible cell-free antibacterial reaction in hemolymph of Samia cynthia pupae. Infect Immun 1974, 10:136-145.
12. Rudolph B., Podschun R., Sahly H., Schubert S., Schröder J.M., Harder J. Identification of RNase 8 as a novel human antimicrobial protein. Antimicrob Agents Chemother 2006, 50:3194-3196.
13. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 2006, 8:11-26.
14. Nuding S., Zabel L.T., Enders C., Porter E., Fellermann K., Wehkamp J., et al. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3. Microbes Infect 2009, 11:384-393.
15. Urbán E., Nagy E., Pál T., Sonnevend A., Conlon J.M. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria. Int J Antimicrob Agents 2007, 29:317-321.